Arax Advisory Partners’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12
Closed -$204 1327
2023
Q4
$204 Buy
+12
New +$238 ﹤0.01% 1277

Other funds holding BTAL

Arax Advisory Partners's BTAL Position: Q1 2024 in Review

Arax Advisory Partners sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q1 2024, closing a stake of 12 shares — an estimated $204 sold.

Arax Advisory Partners first reported a position in BTAL in Q4 2023 and held it in 1 quarter. The position peaked at $204 in Q4 2023. 61 funds tracked by Wall St. Rank hold BTAL as of Q1 2024.

  • Arax Advisory Partners reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q1 2024 after selling out during the quarter.
  • Arax Advisory Partners sold 12 AGF US Market Neutral Anti-Beta Fund shares in Q1 2024, an estimated $204.
  • Arax Advisory Partners first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2023 and held it in 1 quarter.
  • Arax Advisory Partners's AGF US Market Neutral Anti-Beta Fund position peaked at $204 in Q4 2023.
  • 61 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2024.

Based on Arax Advisory Partners's 13F filing for Q1 2024, filed 14 May 2024.